��ֳ� at EADV 2024: committed to advancing care in immuno-dermatology

Vandenbruaene Nathalie — Wed, 25 Sep 2024 07:06:18 +0000

Eimear O'Brien, Corporate Communications

Vandenbruaene … Wed 25/09/2024 - 09:06

As the European Academy of Dermatology and Venerology (EADV) annual congress approaches, ��ֳ� proudly reaffirms its commitment to advancing immuno-dermatology care. This prestigious event unites leading dermatologists, scientists, and healthcare professionals to share the latest research and address critical unmet needs. We are excited to explore how the scientific advancements showcased at this year’s congress in Amsterdam can enhance our ability to serve people living with dermatological diseases.

��ֳ� stands with the scientific, medical, and patient communities, working together to raise the standard of care in immuno-dermatology. Our participation at EADV reflects our commitment to investing in the science that can enable better outcomes for people living with immune-mediated inflammatory diseases. This year, we are proud to have 23 abstracts accepted across our immuno-dermatology portfolio contributing to the understanding of conditions like psoriasis, psoriatic arthritis (PsA) and hidradenitis suppurativa (HS).

Our exhibition booth this year will serve as an exciting hub for engagement and education. We will share our disease awareness initiatives in HS to deepen understanding of this painful and often debilitating condition. Visitors can also learn about our ongoing research, patient support programs, and our commitment to improving the lives of those affected by dermatological diseases.

As part of our commitment to furthering knowledge and understanding in dermatology, we are hosting two scientific symposia that will delve deeper into psoriasis and HS.

As we look forward to EADV 2024, ��ֳ� remains steadfast in our mission to advance immuno-dermatology care. By collaborating with the scientific and medical communities, and championing research, we are committed to improving patient outcomes.

If you are a healthcare professional attending EADV, join us at our scientific symposia or visit our booth to learn more. We look forward to meeting you in Amsterdam!

about ucb

166 Likes

Innovating and collaborating in immuno-dermatology: a dialogue with ��ֳ�’s Simon Lucas & Camille Lee

Vandenbruaene Nathalie — Thu, 07 Mar 2024 09:30:58 +0000

Innovating and collaborating in immuno-dermatology: a dialogue with ��ֳ�’s Simon Lucas & Camille Lee

Eimear O'Brien, Global Communications & Company Reputation

Vandenbruaene … Thu 07/03/2024 - 10:30

The 2024 American Academy of Dermatology (AAD) Annual Meeting takes place this week, in San Diego, California. We sat down with Simon Lucas, Global Head of Immuno-Dermatology, ��ֳ�, and Camille Lee, Head of U.S. Immunology, ��ֳ�, to learn more about ��ֳ�’s presence at the meeting and to hear their perspectives on the future of immuno-dermatology.

What can you tell us about the AAD Annual Meeting?

Camille – The 2024 AAD Annual Meeting is a highly anticipated event in the immuno-dermatology calendar. Organized by the American Academy of Dermatology, it is a platform for leading experts to disseminate cutting-edge research. This year, approximately 20,500 attendees from over 100 countries will convene in person to hear the latest developments in the diagnosis, prevention, and treatment of dermatologic conditions. ��ֳ� is a long-standing participant of AAD, and we are privileged to join the community again this year to stay up to date with the latest research and innovations.

Can you tell us about ��ֳ�’s presence at AAD 2024?

Simon – At AAD 2024, we have a strong scientific presence, showcasing sixteen abstracts across three disease areas – psoriasis, psoriatic arthritis and hidradenitis suppurativa. Given the chronic nature of these conditions, and the need for treatment options that provide lasting relief, we are pleased to unveil new four-year data in moderate-to-severe psoriasis and 48-week data in moderate-to-severe hidradenitis suppurativa.

Camille – In addition, delegates will have the opportunity to gain deeper insights into ��ֳ�’s portfolio at our exhibition booth. Healthcare professionals can also familiarize themselves with “Make HStory” our hidradenitis suppurativa disease awareness campaign that aims to bring more attention and awareness to this debilitating disease, as well as provide resources for HCPs and patients alike.

What is ��ֳ�’s current focus in immuno-dermatology?

Simon – We are focused on immuno-dermatological diseases characterized by substantial unmet needs. We have a solid history of connecting patients’ needs to innovative science and ultimately delivering new treatment options. Our mission is to deliver options and support that raise the standard of care, and we’re proud of our achievements so far. Our work is proceeding at a rapid pace. Recognizing that our aspirations cannot be realized alone, we actively collaborate with the community to advance our common goals. By working together today, we hope to improve the lives of more people living with immuno-dermatological conditions today and into the future.

How is ��ֳ� demonstrating its commitment to the community?

Camille – We are lucky to have a highly passionate team that is motivated each day by our company ethos “Inspired by patients. Driven by science.” Despite recent advances in therapy, people living with immuno-dermatological conditions still face significant unmet needs. That is why alongside our focus on developing new treatments, we partner and support causes that are important to the community. In the U.S., for example, our support of The HS Coalition, a leading group of patient advocates and healthcare professionals, showcases our commitment and how we strive to address disparities and improve outcomes in hidradenitis suppurativa. In addition, our collaboration with advocacy groups enables us to gain real-world insights that we use to help improve the lives of people with immuno-dermatologic diseases.

What do you envision for the future of immuno-dermatology?

Simon – We are in a significant era of scientific advancement in immuno-dermatology, where ground-breaking research is deepening our understanding of the skin immune response. The future is bright with science, innovation, and collaboration driving rapid advancement. With our existing portfolio and ongoing research in new disease areas and populations, ��ֳ� is proud to contribute and reinforce our commitment to the community.

Do you have a final message for delegates attending the meeting?

Camille – Patients are at the heart of everything we do at ��ֳ� and this year’s meeting offers an exciting opportunity to learn about the latest research, exchange ideas, and collectively shape the future of immuno-dermatology for patients. Through our work with those living with psoriasis and HS, we know that patients continue to need more support in managing their condition. We are excited to engage with attendees about how ��ֳ� can continue to help people living with immuno-dermatologic conditions. If you plan to attend, we invite you to visit our exhibition booth or join us at our scientific symposium. We look forward to connecting with you in San Diego. Safe travels!

��ֳ� has a proven heritage in immunology. We harness evidence-based science to deliver solutions and services that address persistent unmet needs across the healthcare ecosystem. By leveraging data, technology, and innovative scientific research we aim to improve the lives of people living with these diseases.

about ucb

AAD 2024 American Academy of Dermatology Annual Meeting Immuno-Dermatology

136 Likes

Immuno-Dermatology

��ֳ� at EADV 2024: committed to advancing care in immuno-dermatology

Leave a Comment

Innovating and collaborating in immuno-dermatology: a dialogue with ��ֳ�’s Simon Lucas & Camille Lee

Leave a Comment

Immuno-Dermatology

������ֳ� at EADV 2024: committed to advancing care in immuno-dermatology

Leave a Comment

Innovating and collaborating in immuno-dermatology: a dialogue with ������ֳ�’s Simon Lucas & Camille Lee

Leave a Comment

��ֳ� at EADV 2024: committed to advancing care in immuno-dermatology

Innovating and collaborating in immuno-dermatology: a dialogue with ��ֳ�’s Simon Lucas & Camille Lee